Nicole Fawcett
Director of Communications, University of Michigan Rogel Cancer

Fawcett leads a team of communicators who produce targeted, innovative communication for the Rogel Cancer Center’s research and clinical enterprises. Prior to Michigan Medicine, Fawcett was a reporter at the Detroit News and editor for a web-based community for people with disabilities.
Nicole Fawcett photo
purple white
Health Lab
Study defines key driver of aggressive ovarian cancer
A study explains the genetic underpinnings of a rare and aggressive form of ovarian cancer – and offers a potential pathway for new treatments.
 pill being taken close up with water near hand
Health Lab
Patients are opting in for 10 years of breast cancer treatment
As recommendations suggest extending hormone-based breast cancer treatment to 10 years for some patients, a recent study sheds light on whether patients are opting for it.
 cells purple some lighter cells in white
Health Lab
Researchers find early driver of prostate cancer aggressiveness
University of Michigan Health Rogel Cancer Center scientists identified a gene that plays a key role in prostate cancer cells that have transitioned to a more aggressive, treatment-resistant form. The gene can be indirectly targeted with an existing class of drugs, suggesting a potential treatment strategy for patients with aggressive subtypes of prostate cancer.
 Susan and Richard Rogel are standing together behind a table. Susan is leaning over with a pen in her hand to sign a gift agreement. She's smiling and looking at someone out of the frame. Richard is smiling and looking directly at the camera.
Medicine at Michigan
Rogel Cancer Center receives $50M to revolutionize pancreatic cancer care and research
Susan and Richard Rogel have given $50 million to create the Rogel and Blondy Center for Pancreatic Cancer at Michigan Medicine.
 two women hugging with cap over hair
Health Lab
Study offers reassurance for patients with some cancer-linked genes
Research by the University of Michigan Health Rogel Cancer Center finds that patients with three of these variants face no extra risk of dying from their cancer.
Health Lab
4 exciting advances in multiple myeloma
A specialist outlines some recent advances that have him excited for the future of multiple myeloma treatment.
 patient looking at paper with provider in scrubs blue in clinic
Health Lab
How race impacts patients’ response to cancer immunotherapy
The first large scale analysis finds immune checkpoint inhibitors are equally effective in Black and white patients, with Black patients having fewer side effects.
 close up of orange and purple squiggle-looking cells merging and a little green in the middle
Health Lab
Researchers find metabolic mechanism that blocks immune response, immunotherapy in cancer
New research has discovered why some cancers don’t respond to immunotherapy treatment: A metabolite transporter within the tumor microenvironment blocks a key type of tumor cell death integral to immune response.
 Susan and Richard Rogel pose next to a grand piano. Rogel is wearing a polo shirt with a block M.
News Release
Rogel Cancer Center receives $50M gift to revolutionize pancreatic cancer care, research
New Rogel and Blondy Center for Pancreatic Cancer will bring together researchers and clinicians to drive forward new treatments and improve outcomes
 Sewing Machine Cell Fabric Tangled
Health Lab
Research points to potential new treatment for aggressive prostate cancer subtype
In two separate papers, U-M researchers describe how a gene alteration drives prostate cancer and a potential degrader that stops it
 purple cells attached and merging
Health Lab
Organoid model predicts bladder cancer treatment response
Researchers have developed a new model to help predict treatment response in patients with bladder cancer. 
 rx bottle orange see through person paying in background
Health Lab
New law regulating out-of-pocket drug spending saves cancer patients more than $7,000 a year
A study finds that efforts to cap prescription drug spending are yielding significant out-of-pocket savings for these patients.
 blue cells close up with orangey see through circle going in and an explosion of bright yellow orange to the far left in that circle with purple circles floating in background
Health Lab
Researchers identify factor that drives prostate cancer-causing genes
Researchers have uncovered a key reason why a typically normal protein goes awry and fuels cancer. They found the protein NSD2 alters the function of the androgen receptor, an important regulator of normal prostate development.
 two women, one older one younger, looking concerned listening to a provider across from them with back to camera
Health Lab
Many breast cancer survivors don't receive genetic testing, despite being eligible
As cancer treatment and survivorship care relies more on understanding the genetic make up of an individual’s tumor, a study from the University of Michigan Health Rogel Cancer Center finds that many breast cancer survivors who meet criteria for genetic counseling and testing are not receiving it.
 Cancer cell microscopic, colored yellow
Health Lab
Researchers find common immune system mechanism between pregnancy, cancer
Researchers find common immune system mechanism between pregnancy, cancer
  • 1
  • 2
  • 3
    •